Osteonecrosis of Femoral Head
7
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH)
DEXA Bone Density Analysis of the CoreHip® Prosthesis System
Squeaking in Ceramic-on-Ceramic Total Hip Arthroplasty Using Delta TT Cup
LPB Combined with QLB Using Single-needle Technique (LPQLB-SNT) for Hip Arthroplasty
Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip
Transcription Factor Runx2 in Necrotic Femoral Head Tissue
Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old